CTEC FINANCIAL STATEMENTS

ConvaTec Group PLC — balance sheet, income statement and cash flow trends

CTECConvaTec Group PLC

🇬🇧 UK · LSE · Healthcare · Medical Instruments & Supplies

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q2 2025 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue2.4 B $+14.1%

Gross Profit1.4 B $+13.0%

Operating Income403.6 M $+53.6%

EBITDA619.6 M $+32.6%

Net Income175.3 M $+34.6%

Peer Comparison· Medical Instruments & Supplies

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
CTEC	6.8%	55.8%	25.3%	7.2%
EMBC	-3.4%	62.5%	30.9%	10.7%
KRMD	23.3%	61.5%	-3.4%	-5.3%
SMTI	17.4%	91.2%	7.7%	-31.2%
HBIO	-6.4%	57.1%	-2.2%	-11.4%
UTMD	-4.4%	53.6%	43.6%	28.9%
Industry median	6.4%	53.7%	13.8%	3.9%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q2 2025

Equity1.5 B $40%
Current Liabilities616.2 M $16%
Long-term Liabilities1.6 B $44%

Key Figures

YoY change

Total Assets3.8 B $+1.8%

Total Liabilities2.3 B $+12.0%

Total Equity1.5 B $-10.3%

Cash & ST Investments75 M $-23.7%

Total Debt1.5 B $+15.7%

Net Debt1.4 B $+18.8%

Peer Comparison· Medical Instruments & Supplies

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
CTEC	1.53	100.0%	2.33	40.1%
EMBC	2.46	-216.9%	3.64	-60.8%
KRMD	2.33	19.9%	3.68	59.2%
SMTI	2.28	688.1%	4.17	10.1%
HBIO	1.99	439.2%	-19.80	12.9%
UTMD	28.64	0.2%	-5.33	96.8%
Industry median	2.40	34.8%	1.44	62.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q2 2025 · TTM

Key Figures

YoY change

Operating Cash Flow466 M $+34.8%

Capital Expenditures120.8 M $-6.5%

Free Cash Flow345.2 M $+59.5%

Dividends Paid-136.9 M $-223.6%

Peer Comparison· Medical Instruments & Supplies

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
CTEC	19.1%	14.1%	4.9%	265.8%
EMBC	20.5%	19.6%	0.8%	190.8%
KRMD	1.7%	0.3%	1.3%	-31.4%
SMTI	5.9%	3.1%	2.7%	-18.8%
HBIO	3.6%	1.7%	1.9%	-31.5%
UTMD	35.5%	34.7%	0.8%	122.9%
Industry median	13.8%	8.6%	3.8%	128.3%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on CTEC

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.